Earlier Use of CAR T Cells Holds Promise in Blood Cancers, But Access Remains an Issue
A panel of experts at the American Society of Clinical Oncology Annual Meeting presented the latest research and equity considerations for chimeric antigen receptor (CAR) T-cell therapy in hematological cancers.
Source: ajmc.com